Genetics

The AmplideX suite of products is designed to solve unmet testing needs in inherited genetic disorders. The technology overcame a 20-year challenge by reliably amplifying the FMR1 gene. This allowed researchers to gain a deeper understanding of fragile X syndrome, the most commonly known inherited cause of intellectual disability and autism.

Asuragen pioneered innovation in three major areas:

• Reduced Complexity
  Amplification and analysis of GC-rich and high homology target sequences
• Optimised Workflow
  Assay and informatics solutions to optimise efficiency, hands-on time and cost
• Quality Performance
  Accuracy, sensitivity, specificity and reproducibility with FMR1